 PHILADELPHIA, Sept. 26, 2022 GLOBE NEWSWIRE -- Century Therapeutics NASDAQ: IPSC, an innovative biotechnology company developing induced pluripotent stem cell iPSC-derived cell therapies in immuno-oncology, today announced that Lalo Flores, Ph.D., Chief Executive Officer, will participate in a panel titled Next Generation Gene Editing at Chardans 6th Annual Genetic Medicines Conference on Monday, October 3, 2022, at 10:30 AM ET. 